Early Detection of Lung Cancer and Mesothelioma in Workers Exposed to Asbestos

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01719068

Enrollment

200

Registered

2012-11-01

Start date

2012-10-31

Completion date

2014-12-31

Last updated

2012-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer, Mesothelioma

Keywords

Mesothelioma, Lung Cancer, Early Detection

Brief summary

This is a pilot study that aims to develop a lung cancer screening program for workers in British Columbia, Canada exposed to asbestos who are at risk of developing lung cancer/pleural mesothelioma. This is high risk population is at of respiratory system diseases as a result of their occupational exposures. Additionally, knowledge garnered from this study will allow us to develop other studies that will further our understanding of asbestos related lung cancer and mesothelioma.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

50 Years to 79 Years

Healthy volunteers

Yes

Inclusion criteria

* Women or men age 50 to 79 years * history of exposure to asbestos at work and one or more of the following: * lung cancer risk ≥2% over 3 years or * asbestosis or pleural plaques on a chest x-ray or * abnormal auto-antibodies level using the EarlyCDT test * Capable of providing informed consent for screening procedures (low dose spiral CT, lung function, blood biomarkers).

Exclusion criteria

* Any medical condition, such as severe heart disease (e.g. unstable angina, chronic congestive heart failure), acute or chronic respiratory failure, or any disorder, that in the opinion of the physician unlikely to benefit from screening due to shortened life-expectancy from co-existing illnesses * Have been previously diagnosed with mesothelioma * Have had other cancer within the past 5 years with the exception of the following cancers: non-melanomatous skin cancer,localized prostate cancer, carcinoma in situ (CIS) of the cervix, or superficial bladder cancer. Treatment of the exceptions must have ended \>6 months before registration into this study * Pregnancy * Unwilling to have a low dose CT scan of chest * Unwilling to sign a consent

Design outcomes

Primary

Measure	Time frame
Development of Model to Predict Workers at highest risk of lung cancer/mesothelioma	3 years

Countries

Canada

Contacts

Primary ContactSharon Gee

sgee@bccancer.bc.ca604-675-8089

Outcome results